Related Experiment Video
Updated: Nov 26, 2025

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both?
1Department of Biochemistry, Virginia Tech, Blacksburg, VA 24061, USA.
Abstract:
Fusobacterium nucleatum is an oral bacterium associated with colorectal cancer (CRC) proliferation, chemoresistance, inflammation, metastasis, and now DNA damage. While controlling F. nucleatum through antibiotics could reduce cancer severity, this article proposes additional strategies to block Fusobacterium-host interactions, as well as treatment of activated host immune and oncogenic signaling pathways in CRC.
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Targeted Cancer Therapies
There are several types of targeted therapies against...
Intracellular Movement of Viruses and Bacteria
The Tumor Microenvironment
Mitogens and the Cell Cycle
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

